Related Experiment Video
Updated: Oct 5, 2026

Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Fungal infections in lung transplantation. Incidence, risk factors and prognostic significance
E Ruffini1, S Baldi, M Rapellino
1Department of Thoracic Surgery, University of Torino, 3, Via Genova, 10126 Torino, Italy. enrico.ruffini@unito.it
Background And Aim Of The Work:
Fungal infections are frequent following lung transplantation and are associated with high mortality and morbidity. The study aims at 1) reporting our experience with fungal infections after lung transplantation; 2) identifying statistically significant correlations between the occurrence of fungal infections and bacterial infections, cytomegalovirus disease, rejection and steroid therapy; 3) assessing whether the presence of fungal infection has an impact on long-term survival.
Methods:
60 lung transplant recipients were studied with respect to incidence, pattern of presentation and median time to presentation of fungal infection after the transplant. Correlation analysis of the variables of interest was undertaken in 30 patients who had a minimum follow-up of 1 year following transplant.
Results:
The prevalence of fungal infection was 44%; severe infections occurred in 5 patients (11%). The presence of Candida preoperatively was not associated with an increased risk of fungal infection. In a logistic regression analysis, a significant correlation was found between the occurrence of fungal infection and the following variables: respiratory bacterial infections (p = 0.0003), cytomegalovirus disease (p = 0.00001) and steroid therapy (p = 0.04). No statistically significant difference was found between patients who experienced a fungal infection and those who did not, either in univariate or multivariate survival analysis (p = 0.08).
Conclusions:
1) fungal infections are frequent in lung transplant recipients and may be severe in more than 10% of the cases; 2) the presence of fungi preoperatively is not a contraindication to transplantation: an antifungal prophylaxis is probably indicated in such cases postoperatively; we recommend the use of the less nephrotoxic liposomal Amphotericin B by aerosol route; 3) a statistically significant association exists between fungal infections and both steroid therapy and CMV disease; this suggests that a similar antifungal prophylaxis is indicated in these clinical circumstances; 4) the presence of fungal infection is not an independent prognostic factor of long-term survival.
Insights
Fungal infections are common after lung transplants, often linked to bacterial infections, cytomegalovirus disease, and steroid use. However, these infections do not impact long-term survival rates in transplant recipients.
Area of Science:
- Infectious Diseases
- Transplantation Medicine
- Pulmonology
Background:
- Fungal infections pose a significant threat to lung transplant recipients, contributing to high mortality and morbidity.
- Understanding the risk factors and outcomes of these infections is crucial for improving patient care.
Purpose of the Study:
- To report institutional experience with fungal infections post-lung transplantation.
- To identify correlations between fungal infections and bacterial infections, cytomegalovirus (CMV) disease, rejection, and steroid therapy.
- To assess the impact of fungal infections on long-term survival after lung transplantation.
Main Methods:
- A retrospective study of 60 lung transplant recipients.
- Analysis of incidence, presentation patterns, and time to fungal infection.
- Correlation analysis in 30 patients with at least 1-year follow-up.
Main Results:
- Fungal infections occurred in 44% of patients, with severe infections in 11%.
- Significant correlations were found between fungal infections and respiratory bacterial infections (p=0.0003), CMV disease (p=0.00001), and steroid therapy (p=0.04).
- No statistically significant impact of fungal infection on long-term survival was observed (p=0.08).
Conclusions:
- Fungal infections are frequent and can be severe in lung transplant recipients.
- Preoperative fungal presence does not contraindicate transplantation; postoperative antifungal prophylaxis, such as aerosolized liposomal Amphotericin B, is recommended.
- Fungal infections are associated with steroid therapy and CMV disease, suggesting prophylaxis in these scenarios. Fungal infection is not an independent predictor of long-term survival.
Related Concept Videos
Cryptococcal Meningitis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction

